West Pharmaceutical Services Inc (WST) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Total Assets Chart for West Pharmaceutical Services Inc
West Pharmaceutical Services Inc (WST) total assets for FY2025 were USD 4.3B, a 17.2% change from FY2024. West Pharmaceutical Services Inc's total assets grew from USD 179.0M in 1985 to USD 4.3B in 2025 (2285.5% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 8.9%, 10-year CAGR of 9.7%, 20-year CAGR of 8.6%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $24.53B
- Implied Share Price
- $348.60
- Enterprise Value
- $24.42B
- Revenue (TTM)
- $3.33B
- EBITDA
- $912.20M
- Profit Margin
- 16.98%
- Trailing P/E
- 45.04
- Forward P/E
- 39.53
- Price/Book (MRQ)
- 8.21
- Price/Sales (TTM)
- 7.37
- EV/EBITDA
- 27.77
- EV/Revenue
- 7.34
- Dividend Yield
- 0.25%
- Book Value
- $42.47
- Free Cash Flow (FY2025)
- $468.90M
- Free Cash Flow Yield
- 1.91%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.